In the last few decades, DNA analysis has transformed the field of microbiology.
Culture techniques previously the standard leave up to 50% of bacterial species virtually invisible. The GI-MAP utilizes cutting-edge FDA-approved technology to provide a true DNA-based assessment of a patient’s gut microbiome from a single stool sample. This arms the clinician with actionable information on microbes that are well-researched to cause disease or disrupt normal microbial balance and contribute to many inflammatory, autoimmune, metabolic, cardiovascular, and other chronic diseases.
This is why it is the methodology of choice for microbiome researchers and now via Diagnostic Laboratory to Functional and Integrative Medicine practitioners for better patient outcomes.